GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (XTER:GXI) » Definitions » EBITDA Margin %

Gerresheimer AG (XTER:GXI) EBITDA Margin % : 17.41% (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Gerresheimer AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Gerresheimer AG's EBITDA for the three months ended in Feb. 2024 was €81 Mil. Gerresheimer AG's Revenue for the three months ended in Feb. 2024 was €466 Mil. Therefore, Gerresheimer AG's EBITDA margin for the quarter that ended in Feb. 2024 was 17.41%.


Gerresheimer AG EBITDA Margin % Historical Data

The historical data trend for Gerresheimer AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG EBITDA Margin % Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.21 21.24 19.62 18.73 20.29

Gerresheimer AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.77 21.67 20.58 21.72 17.41

Competitive Comparison of Gerresheimer AG's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's EBITDA Margin % falls into.



Gerresheimer AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Gerresheimer AG's EBITDA Margin % for the fiscal year that ended in Nov. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Nov. 2023 )/Revenue (A: Nov. 2023 )
=403.89/1990.486
=20.29 %

Gerresheimer AG's EBITDA Margin % for the quarter that ended in Feb. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=81.174/466.138
=17.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gerresheimer AG  (XTER:GXI) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Gerresheimer AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG (XTER:GXI) Business Description

Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Executives
Dietmar Siemssen Board of Directors
Dr. Lukas Burkhardt Board of Directors
Andrea Abt Supervisory Board

Gerresheimer AG (XTER:GXI) Headlines

No Headlines